Cover Image
Market Research Report

Anthrax Global Clinical Trials Review, H2, 2018

Published by GlobalData Product code 371760
Published Content info 75 Pages
Delivery time: 1-2 business days
Price
Back to Top
Anthrax Global Clinical Trials Review, H2, 2018
Published: October 31, 2018 Content info: 75 Pages
Description

GlobalData's clinical trial report, "Anthrax Global Clinical Trials Review, H2, 2018" provides an overview of Anthrax clinical trials scenario. This report provides top line data relating to the clinical trials on Anthrax. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5420CTIDB

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Clinical Trials by G7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Anthrax to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Anthrax Therapeutics Clinical Trials 29
  • Prominent Drugs 31
  • Clinical Trial Profile Snapshots 32

Appendix 73

  • Abbreviations 73
  • Definitions 73
  • Research Methodology 74
  • Secondary Research 74
  • About GlobalData 74
  • Contact Us 75
  • Source 75

List of Tables

  • Anthrax Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Anthrax Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Anthrax Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Anthrax Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Anthrax Therapeutics Clinical Trials, Europe, Top Countries, 2018* 12
  • Anthrax Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Proportion of Anthrax to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 14
  • Anthrax Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
  • Anthrax Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
  • Proportion of Anthrax to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 17
  • Anthrax Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
  • Anthrax Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 19
  • Anthrax Therapeutics, Global, Clinical Trials by Phase, 2018* 20
  • Anthrax Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21
  • Anthrax Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Anthrax Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Anthrax Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Anthrax Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Anthrax Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
  • Anthrax Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30
  • Anthrax Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31

List of Figures

  • Anthrax Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Anthrax Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Anthrax Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Anthrax Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Anthrax Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 12
  • Proportion of Anthrax to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 14
  • Anthrax Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
  • Anthrax Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
  • Proportion of Anthrax to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 17
  • Anthrax Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
  • Anthrax Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 19
  • Anthrax Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20
  • Anthrax Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21
  • Anthrax Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
  • Anthrax Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Anthrax Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Anthrax Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Anthrax Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Anthrax Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
  • Anthrax Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 31
  • GlobalData Methodology 74
Back to Top